Osteoporosis in type II diabetes.

Area of Science:

• Endocrinology
• Metabolic Disorders
• Bone Health

Background:

• Type II diabetes mellitus (T2DM) is a prevalent metabolic disorder.
• Osteoporosis is a significant public health concern, characterized by low bone mass and microarchitectural deterioration.
• The relationship between T2DM and bone health requires further elucidation.

Purpose of the Study:

• To compare lumbar bone mineral content (BMC) in women with well-compensated T2DM and age-matched non-diabetic controls.
• To investigate the presence and degree of osteoporosis in T2DM using dual-photon absorptiometry.
• To assess potential differences in bone health based on T2DM treatment (diet vs. oral hypoglycemics).

Main Methods:

• Dual-photon absorptiometry was employed for precise measurement of lumbar BMC.
• Study included 40 women with T2DM (dietary and/or oral hypoglycemic treatment) and 35 age-matched non-diabetic women.
• Blood and urinary levels of calcium, phosphorus, parathyroid hormone (PTH), and thyrocalcitonin were analyzed.

Main Results:

• No significant differences were observed in blood calcium, phosphorus, PTH, thyrocalcitonin, or urinary calcium and phosphorus between the groups.
• Lumbar BMC was significantly lower in women with T2DM compared to controls, specifically in the L2-L4 region and L4 alone.
• No significant difference in BMC was found between diabetic patients on diet versus those on oral hypoglycemic drugs.

Conclusions:

• Osteoporosis is a potential complication of type II diabetes mellitus.
• Reduced bone mineral content in T2DM may occur independently of classical diabetes complications or differences in key metabolic markers.
• This study highlights the importance of assessing bone health in patients with type II diabetes.